Oncology PracticeSurgery adds little after successful chemo in metastatic breast cancerDecember 13, 2013Breast Cancer
Oncology PracticeNo gain seen from adjuvant bevacizumab in HER2-positive diseaseDecember 13, 2013Breast Cancer
Oncology PracticeIBIS-II: Anastrozole highly effective in preventing breast cancerDecember 13, 2013Breast CancerPreventive Care
Oncology PracticeDasatinib gives letrozole a boost in HR-positive advanced breast cancerDecember 12, 2013Breast Cancer
Oncology PracticeVIDEO: Tumor-infiltrating lymphocytes may predict trastuzumab successDecember 12, 2013Breast Cancer
Oncology PracticeRadiotherapy can be omitted for many older breast cancer patientsDecember 12, 2013Breast Cancer
Oncology PracticePathologic complete response to HER2 therapy portends better outcomesDecember 12, 2013Breast Cancer
Oncology PracticeDr. William Gradishar and Dr. Hope Rugo report from SABCSDecember 11, 2013Breast Cancer
Oncology PracticeCanadian agency reports rare, severe skin reactions to cancer drug December 4, 2013GastroenterologyBreast CancerGI OncologyPatient & Survivor CareGastrointestinal Cancer
Oncology PracticeSan Antonio symposium offers latest results from Neo ALTTO, I-SPY 2, and IBIS-IIDecember 2, 2013Breast Cancer
The Journal of Community and Supportive OncologyIllness perceptions matter: understanding quality of life and advanced illness behaviors in female patients with late-stage cancerDecember 1, 2013Patient & Survivor CareBreast CancerGynecologic CancerLung Cancer
Oncology PracticeSimple intensity-modulated radiotherapy improves breast cancer cosmesisNovember 26, 2013Breast Cancer
Oncology PracticeGenetic profiling transforms cancer treatment trialsNovember 22, 2013Breast CancerGastroenterologyLung CancerPreventive CareGastrointestinal Cancer